Chaoying Zhan
Chaoying Zhan has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Bairong Shen
Department of Respiratory and Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China
2 shared publications - Rongrong Wu
Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China
2 shared publications - Xingyun Liu
Affiliations Health Management Center, General Practice Medical Center and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China, Department of Computer Science and Information Technology, University of A Coruña, Coruña, Spain
2 shared publications - Yingbo Zhang
Tropical Crops Genetic Resources Institute, Chinese Academy of Tropical Agricultural Sciences, Danzhou 571737, China
2 shared publications Bingqing Liu
1 shared publication- Cheng Bi
Department of Ophthalmology and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, No.2222, Xinchuan Road, Gaoxin District, Chengdu, Sichuan, 610041, China, 86 15995854635
1 shared publication
Latest Publications
- Open Access
- 10 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
PEP-DSS-DBC1.0: A Personalized Exercise Prescription Decision Support System for Diabetes Care (Preprint)
BACKGROUND Exercise plays a critical role in managing diabetes, improving glycemic control, and reducing the risk of cardiovascular complications. However, personalizing exercise prescriptions (PEPs) to address individual characteristics and preferences is challenging, particularly in an environment with a global shortage of exercise professionals. While digital tools hold promise for improving personalized care, many existing systems rely on generalized guidelines or expert consensus, lacking the ability to provide highly individualized and evidence-based recommendations. To address this gap, we developed PEP-DSS-DBC1.0, a knowledge-based digital decision support system for generating tailored PEPs in diabetes care. OBJECTIVE The aim of this study was to create a digital, knowledge-based decision support tool for personalized exercise prescriptions that incorporates individual characteristics and preferences. PEP-DSS-DBC1.0 was designed to enhance the precision and usability of PEPs for people with diabetes while ensuring alignment with evidence-based principles. METHODS The development of PEP-DSS-DBC1.0 was informed by an extensive review of the literature. A working group, including experts in exercise medicine, diabetes care, and informatics, was formed to establish a decision support framework. The PubMed database served as the primary resource for knowledge extraction, covering studies published between January 1975 and May 2023. Data from 938 studies were annotated, resulting in 1,171 exercise protocols, 10,316,497 patient records, and 2,904 additional entries, totaling 13,263 data points. The web-based tool was built using a browser/server architecture and the WIMA (Windows, IIS, MySQL, ASP.NET) web stack. Validation and comparative analysis of the tool were performed against ChatGPT4o and sports physicians, using multiple metrics and two rating scales: the System Usability Scale (SUS) and the Net Promoter Score (NPS). RESULTS PEP-DSS-DBC1.0 provides personalized exercise prescriptions based on the newly developed “FITT-VP-WC” principles, which include frequency, intensity, time, type, volume, progression, warning, and contraindication. The tool demonstrated superior performance compared to ChatGPT4o and sports physicians, achieving a total performance score of 100% compared to 48% for ChatGPT4o and 12% for sports physicians (χ2=853.3, P<.001). Usability assessments showed that the average SUS score was 77.25 ± 6.06, indicating above-average usability, while the NPS score was 68.75%, reflecting high user loyalty and satisfaction. The tool is freely accessible at http://PEP-DSS-DBC.sysbio.org.cn/. CONCLUSIONS PEP-DSS-DBC1.0 represents a significant advancement in diabetes care, providing a knowledge-based system for generating highly individualized exercise prescriptions. While the tool has demonstrated superior performance and usability, future randomized controlled trials are essential to further validate its clinical utility and broader application in diabetes management.
- 10 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPEP-DSS-DBC1.0: A Personalized Exercise Prescription Decision Support System for Diabetes Care (Preprint)
BACKGROUND Exercise plays a critical role in managing diabetes, improving glycemic control, and reducing the risk of cardiovascular complications. However, personalizing exercise prescriptions (PEPs) to address individual characteristics and preferences is challenging, particularly in an environment with a global shortage of exercise professionals. While digital tools hold promise for improving personalized care, many existing systems rely on generalized guidelines or expert consensus, lacking the ability to provide highly individualized and evidence-based recommendations. To address this gap, we developed PEP-DSS-DBC1.0, a knowledge-based digital decision support system for generating tailored PEPs in diabetes care. OBJECTIVE The aim of this study was to create a digital, knowledge-based decision support tool for personalized exercise prescriptions that incorporates individual characteristics and preferences. PEP-DSS-DBC1.0 was designed to enhance the precision and usability of PEPs for people with diabetes while ensuring alignment with evidence-based principles. METHODS The development of PEP-DSS-DBC1.0 was informed by an extensive review of the literature. A working group, including experts in exercise medicine, diabetes care, and informatics, was formed to establish a decision support framework. The PubMed database served as the primary resource for knowledge extraction, covering studies published between January 1975 and May 2023. Data from 938 studies were annotated, resulting in 1,171 exercise protocols, 10,316,497 patient records, and 2,904 additional entries, totaling 13,263 data points. The web-based tool was built using a browser/server architecture and the WIMA (Windows, IIS, MySQL, ASP.NET) web stack. Validation and comparative analysis of the tool were performed against ChatGPT4o and sports physicians, using multiple metrics and two rating scales: the System Usability Scale (SUS) and the Net Promoter Score (NPS). RESULTS PEP-DSS-DBC1.0 provides personalized exercise prescriptions based on the newly developed “FITT-VP-WC” principles, which include frequency, intensity, time, type, volume, progression, warning, and contraindication. The tool demonstrated superior performance compared to ChatGPT4o and sports physicians, achieving a total performance score of 100% compared to 48% for ChatGPT4o and 12% for sports physicians (χ2=853.3, P<.001). Usability assessments showed that the average SUS score was 77.25 ± 6.06, indicating above-average usability, while the NPS score was 68.75%, reflecting high user loyalty and satisfaction. The tool is freely accessible at http://PEP-DSS-DBC.sysbio.org.cn/. CONCLUSIONS PEP-DSS-DBC1.0 represents a significant advancement in diabetes care, providing a knowledge-based system for generating highly individualized exercise prescriptions. While the tool has demonstrated superior performance and usability, future randomized controlled trials are essential to further validate its clinical utility and broader application in diabetes management.
- Open Access
- 12 January 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Unveiling Male Infertility Research Hotspots: Leveraging ChatGPT's Information Enhancement for Clinical Translation (Preprint)
BACKGROUND Infertility is a significant negative factor affecting societal population growth and economic stability, with male infertility being a major cause of infertility. In recent years, with the development and advancement of next-generation sequencing technologies and high-resolution mass spectrometry, the volume of male infertility-related literature in scientific databases such as Scopus and PubMed has rapidly increased, and its topics have undergone complex changes over the past 50 years. Additionally, the advent of large language models (like ChatGPT) has provided new tools for enhancing traditional literature analysis and topic modeling. OBJECTIVE This research study aims to explore the potential of large language models, such as ChatGPT, in decision support systems for the clinical translation of male infertility research. METHODS Various methods, including bibliometrics, topic modeling, and ChatGPT's question-answer approach, were employed to compare male infertility hotspots between real-world and virtual-world data. Additionally, the study investigated ChatGPT's ability to enhance information in summarizing male infertility hotspots. RESULTS Under the literature evidence of 14,478 male infertility-related papers (12,534 research papers and 1,944 review papers), traditional bibliometric analyses such as annual analysis, country analysis, and high-impact author analysis show that countries like the United States, China, and Italy are major publishers in infertility research, with the United States being the leading technical influencer in male infertility research. Subsequently, results from topic modeling analysis have effectively mapped out the research themes in male infertility over the past 50 years, this analysis highlights key subjects such as 'the impact of gene expression on male infertility', 'the effect of age on sperm parameters', and 'pathogenic genes of male infertility', marking them as recent research hotspots. However, this method falls short in clearly presenting the latest hotspots in male infertility research. Lastly, the integration of ChatGPT information enhancement offers a new dimension in this research. This approach successfully presents the recent hotspots in male infertility, encompassing not only the impact of risk factors like 'Environmental Exposures', 'Genetics', 'Immunological Factors', 'Hormonal Imbalances' on sperm count and quality but also highlighting emerging areas such as 'Precision Medicine' and 'Artificial Intelligence (AI)' in male infertility research. CONCLUSIONS Therefore, combining real-world literature evidence with the capabilities of ChatGPT is crucial for understanding and mapping future trends in this field. CLINICALTRIAL Trial Registration: Not applicable
- 12 January 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessUnveiling Male Infertility Research Hotspots: Leveraging ChatGPT's Information Enhancement for Clinical Translation (Preprint)
BACKGROUND Infertility is a significant negative factor affecting societal population growth and economic stability, with male infertility being a major cause of infertility. In recent years, with the development and advancement of next-generation sequencing technologies and high-resolution mass spectrometry, the volume of male infertility-related literature in scientific databases such as Scopus and PubMed has rapidly increased, and its topics have undergone complex changes over the past 50 years. Additionally, the advent of large language models (like ChatGPT) has provided new tools for enhancing traditional literature analysis and topic modeling. OBJECTIVE This research study aims to explore the potential of large language models, such as ChatGPT, in decision support systems for the clinical translation of male infertility research. METHODS Various methods, including bibliometrics, topic modeling, and ChatGPT's question-answer approach, were employed to compare male infertility hotspots between real-world and virtual-world data. Additionally, the study investigated ChatGPT's ability to enhance information in summarizing male infertility hotspots. RESULTS Under the literature evidence of 14,478 male infertility-related papers (12,534 research papers and 1,944 review papers), traditional bibliometric analyses such as annual analysis, country analysis, and high-impact author analysis show that countries like the United States, China, and Italy are major publishers in infertility research, with the United States being the leading technical influencer in male infertility research. Subsequently, results from topic modeling analysis have effectively mapped out the research themes in male infertility over the past 50 years, this analysis highlights key subjects such as 'the impact of gene expression on male infertility', 'the effect of age on sperm parameters', and 'pathogenic genes of male infertility', marking them as recent research hotspots. However, this method falls short in clearly presenting the latest hotspots in male infertility research. Lastly, the integration of ChatGPT information enhancement offers a new dimension in this research. This approach successfully presents the recent hotspots in male infertility, encompassing not only the impact of risk factors like 'Environmental Exposures', 'Genetics', 'Immunological Factors', 'Hormonal Imbalances' on sperm count and quality but also highlighting emerging areas such as 'Precision Medicine' and 'Artificial Intelligence (AI)' in male infertility research. CONCLUSIONS Therefore, combining real-world literature evidence with the capabilities of ChatGPT is crucial for understanding and mapping future trends in this field. CLINICALTRIAL Trial Registration: Not applicable